Gaudium IVF and Women Health officially enters the Indian stock market today, February 27, 2025. The company is debuting on the BSE and NSE following a successful subscription period that highlighted significant interest from specific investor segments. The listing price is expected to be closely aligned with the upper end of the price band at 79 rupees. Current grey market trends indicate a flat premium, suggesting a stable or muted opening for the shares on their first day of trading. The initial public offering raised a total of 165 crore rupees. This was achieved through a fresh issue of equity valued at 90 crore rupees and an offer for sale totaling 75 crore rupees. The price band for the issue was set between 75 and 79 rupees per share. Investor demand was notable, with the total issue being subscribed 7.27 times. The Non-Institutional Investors (NII) category led the demand with a 14.05 times subscription. Retail investors also showed healthy interest, oversubscribing their portion by 7.60 times, while Qualified Institutional Buyers (QIB) subscribed 1.62 times. Financially, the company has shown consistent growth. In the fiscal year 2025, Gaudium IVF reported a total income of 70.96 crore rupees and a profit after tax of 19.13 crore rupees. The company maintains a strong EBITDA margin of approximately 40.48 percent. The capital raised from the fresh issue is earmarked for strategic growth. Specifically, 50 crore rupees will be used to establish 19 new IVF centers across India. Another 20 crore rupees will be directed toward the repayment or prepayment of existing loans to strengthen the balance sheet. Gaudium IVF operates through a hub-and-spoke model, currently managing over 30 locations, including 7 hubs and 28 spokes. The expansion plan aims to tap into the rising demand for fertility services and medical tourism in India, serving both domestic patients and international clients from the UK, USA, and Africa. The stock will initially be traded in the Trade-for-Trade segment for the first 10 days to manage volatility. Market participants are watching the opening session for signs of long-term stability in the fertility healthcare sector.